Chromosome aberrations in Raynaud's phenomenon

European Journal of Dermatology

Volumn 14, Issue 5, 2004, Pages 327-331

  Porciello, Giovanni ^a,e   Scarpato, Roberto ^b   Storino, Franca ^b   Migliore, Lucia ^b   Ferri, Clodoveo ^c   Cagetti, Francesca ^b   Morozzi, Gabriella ^d   Bellisai, Francesca ^d   Marcolongo, Roberto ^d   Galeazzi, Mauro ^d  

^a Serv Reumatologia Osp M   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

^e Istituto di Reumatologia   (Italy)

Author keywords

Chromosomal breakage; Micronucleus assay; Raynaud's phenomenon; Systemic sclerosis

Indexed keywords

ANTIBODY;

ADULT; ANEUPLOIDY; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DAMAGE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; LYMPHOCYTE CULTURE; MICRONUCLEUS TEST; MOLECULAR BIOLOGY; PERIPHERAL LYMPHOCYTE; PREVALENCE; RAYNAUD PHENOMENON; SCLERODERMA; STATISTICAL SIGNIFICANCE;

ADULT; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICRONUCLEUS TESTS; MIDDLE AGED; RAYNAUD DISEASE;

EID: 4544340385     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Emerit I, Housset J, De Grouchy J, Camus JP. Chromosomal breakage in diffuse scleroderma. A study of 27 patients. Rev Eur Etud Clin Biol 1971 ; 16 : 684-94.
2. Pan SF, Rodnon GP, Deutsch M, Wald N. Chromosomal abnormalities in progressive systemic sclerosis (scleroderma) with consideration of radiation effects. J Lab Clin Med 1975 ; 86 : 300-8.
3. Emerit I. Chromosome instability in collagen disease. Z Rheumatol 1980 ; 39 : 84-90.
4. Wolff DJ, Needleman BW, Wasserman SS, Schwartz S. Spontaneous and clastogen induced chromosomal breakage in scleroderma. J Rheumatol 1991 ; 18 : 837-40.
5. Sherer GK, Jackson BB, Leroy EC. Chromosome breakage and sister chromatid exchange frequencies in scleroderma. Arthritis Rheum 1981 ; 24 : 1409-13.
6. Migliore L, Bevilacqua C, Scarpato R. Cytogenetic study and FISH analysis in lymphocytes of systemic lupus erythematosus (SLE) and systemic sclerosis (SS) patients. Mutagenesis 1999 ; 14 : 227-31.
7. Jabs EW, Tuck-Muller CM, Anhalt GJ, Earnshaw W, Wise RA, Wigley F. Cytogenetic survey in systemic sclerosis: correlation of aneuplaidy with the presence of anticentromere antibodies. Cytogenet Cell Genet 1993 ; 63 : 169-75.
8. Powell FC, Schroeter AL, Winkelmann RK, Dewald GW. Chromosome studies in scleroderma with consideration of anticentromere antibody status and assessment of possible in vitro clastogenic activity. Acta Derm Venereol 1986 ; 66 : 414-8.
9. Porciella G, Scarpato R, Storino F, Cagetti F, Marcolongo R, Migliare L, Ferri C, Galeazzi M. The high frequency of spontaneous micronuclei observed in lymphocytes of systemic sclerosis patients: preliminary results. Reumatisma 2002 ; 54 : 36-9.
10. Porciello G, Scarpato R, Ferri C, Storino F, Cagetti F, Morozzi G, Bellisai F, Migliore L, Marcolongo R, Galeazzi M. Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon. J Rheumatol 2003 ; 6 : 1244-7.
11. Galeazzi M, Anichini C, Morozzi G, Bellisai F, Puddu P, Marcolongo R. Chromosomal abnormalities in peripheral lymphocytes from idiopathic Raynaud's phenomenon patients. Clin Rheumatol 1996 ; 15 : 418-9.
12. Fenech M. The cytokinesis-block micronucleus technique: a detailed description of the method and its application too genotoxicity studies in human population. Mutat Res 1993 ; 285 : 35-44.
13. Scarpato R, Landini E, Migliore L. Acrocentric chromosome frequency in spontaneous human lymphocyte micronuclei, evaluated by dual-colour hybridisation, is neither sex nor age-related. Mutat Res 1996 ; 372 : 195-204.
14. LeRoy EC, Medsger Jr TA. Raynaud's phenomenon: a proposal for classification. Clin Exp Rheumatol 1992 ; 10 : 458-9.
15. Zufferey P, Depairon M, Chamot AM, Monti M. Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study. Clin Rheumatol 1992 ; 11 : 536-41.
16. Sarkozi J, Bookman AA, Lee P, Keystone EC, Fritzler MJ. Significance of anticentromere antibody in idiopathic Raynaud's syndrome. Am J Med 1987 ; 83 : 893-8.
17. Tramposch HD, Smith CD, Senecal JL, Rothfield N. A long-term longitudinal study of anticentromere antibodies. Arthritis Rheum 1984 ; 27: 121-4.
18. Kallenberg CGM, Pastoor GW, Wouda AA, The TH. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies. Ann Rheum Dis 1982 ; 41 : 382-7.
19. Maricq HR, Harper FE, Khan MM, Tan EM LeRoy EC. Microvascular abnormalities as possible predictors or disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1983 ; 1 : 195-205.
20. Kallenberg CG. Early detection of connective tissue disease in patients with Raynaud's phenomenon. Rheum Dis Clin North Am 1990 ; 16 : 11-30.
21. Emerit I. Reactive oxigen species, chromosome mutation and cancer: possible role of clastogenic factors in carcinogenesis. Free Radic Bio Med 1994 ; 16 : 99-109.
22. Emerit I, Arutyunyan R, Oganesian N, Levy A, Cernjavsky L, Sarkisian T, Pogossian A, Asrian K. Radiation-induced clastogenic factors: anticlastogenic effect of Ginkgo biloba extract. Free Radic Biol Med 1995 ; 18 : 985-91.
23. Emerit I, Filipe P, Meunier P, Auclair C, Freitas J, Deroussent A, Gouyette A, Fernandez A. Clostogenic activity in the plasma of scleroderma patients: a biomarker of oxydative stress. Dermatology 1997 ; 194 : 140-6.
24. Emerit I, Serejo F, Filipe P, Alaoui Youssefi A, Fernandes A, Costa A, Freitas J, Ramalho F, Baptista A, Carneiro de Moura M. Clastogenic factors as biomarkers of oxydative stress in chronic hepatitis C. Digestion 2000 ; 62 : 200-7.
25. Simonini G, Matucci Cerinic M, Generini S, Zoppi M, Anichini M, Cesaretti C, Pignone A, Falcini F, Lotti T, Cagnoni M. Oxidative stress in systemic sclerosis. Mol Cell Biochem 1999 ; 196 : 85-91.
26. Herrick AL, Matucci Cerinic M. The emerging problem of oxidative stress and the role of ant-oxidants in systemic sclerosis. Clin Exp Rheumatol 2001 ; 19 : 4-8.
27. Bruckdorfer KR, Hillary JB, Bunce T, Vancheeswaran R, Black CM. Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis. Arthritis Rheum 1995 ; 38 : 1060-7.
28. Sambo P, Jannino L, Candela M, Salvi A, Domini M, Dusi S, Luchetti MM, Gabrielli A. Monocytes of patients with systemic sclerosis (scleroderma) spontaneously release in vitro increased amounts of superoxide anion. J Invest Dermatol 1999 ; 112 : 78-84.
29. Sambo P, Svegliati Baroni S, Luchetti M, Paroncini P, Dusi S, Orlandini G, Gabrielli A. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxigen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 2001 ; 44 : 2653-64.
30. Emerit I, Garban F, Vassy J, Levy A, Filipe P, Freitas J. Superoxide-mediated clastogenesis and anticlastogenic effects of exogenous superoxide dismutase. Proc Natl Acad Sci USA 1996 ; 93 : 12799-804.
31. Foster MH, Kieber-Emmons T, Ohliger M, Madaio MP. Molecular and structural analysis of nuclear localizing anti-DNA lupus antibodies. Immunol Res 1994 ; 13 : 186-206.
32. Yanase K, Smith RM, Cizman B, Foster MH, Peachey LD, Jarret L, Madaio MP. A subgroup of murine monoclonal antideoxyribonucleic acid antibodies traverse the cytoplasm and enter the nucleus in a time- and temperature-dependent manner. Lab Invest 1994 ; 71 : 52-60.